WallStreetZenWallStreetZen

NASDAQ: PROF
Profound Medical Corp Stock

$10.22+0.23 (+2.3%)
Updated Jul 19, 2024
PROF Price
$10.22
Fair Value Price
-$8.46
Market Cap
$249.66M
52 Week Low
$7.11
52 Week High
$12.98
P/E
-10.85x
P/B
7.46x
P/S
34.2x
PEG
N/A
Dividend Yield
N/A
Revenue
$5.29M
Earnings
-$20.31M
Gross Margin
61.2%
Operating Margin
-387.89%
Profit Margin
-381.1%
Debt to Equity
0.25
Operating Cash Flow
-$16M
Beta
1.15
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

PROF Overview

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PROF scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PROF ($10.22) is overvalued by 220.77% relative to our estimate of its Fair Value price of -$8.46 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
PROF ($10.22) is not significantly undervalued (220.77%) relative to our estimate of its Fair Value price of -$8.46 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PROF is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PROF due diligence checks available for Premium users.

Be the first to know about important PROF news, forecast changes, insider trades & much more!

PROF News

Valuation

PROF fair value

Fair Value of PROF stock based on Discounted Cash Flow (DCF)
Price
$10.22
Fair Value
-$8.46
Undervalued by
220.77%
PROF ($10.22) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PROF ($10.22) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PROF is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PROF price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-10.85x
Industry
30.13x
Market
29.62x

PROF price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
7.46x
Industry
3.87x
PROF is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PROF's financial health

Profit margin

Revenue
$1.4M
Net Income
-$727.9k
Profit Margin
-51.8%
PROF's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
PROF's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$42.2M
Liabilities
$8.5M
Debt to equity
0.25
PROF's short-term assets ($40.54M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PROF's short-term assets ($40.54M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PROF's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.7M
Investing
$0.0
Financing
$15.0M
PROF's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PROF vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
PROF$249.66M+2.30%-10.85x7.46x
RCEL$249.48M-2.91%-5.49x7.66x
SENS$247.39M+3.10%-3.33x13.05x
SMLR$236.92M+1.09%10.48x3.04x
VMD$264.37M-3.95%25.22x2.27x

Profound Medical Stock FAQ

What is Profound Medical's quote symbol?

(NASDAQ: PROF) Profound Medical trades on the NASDAQ under the ticker symbol PROF. Profound Medical stock quotes can also be displayed as NASDAQ: PROF.

If you're new to stock investing, here's how to buy Profound Medical stock.

What is the 52 week high and low for Profound Medical (NASDAQ: PROF)?

(NASDAQ: PROF) Profound Medical's 52-week high was $12.98, and its 52-week low was $7.11. It is currently -21.26% from its 52-week high and 43.74% from its 52-week low.

How much is Profound Medical stock worth today?

(NASDAQ: PROF) Profound Medical currently has 24,428,899 outstanding shares. With Profound Medical stock trading at $10.22 per share, the total value of Profound Medical stock (market capitalization) is $249.66M.

Profound Medical stock was originally listed at a price of $9.58 in Oct 30, 2019. If you had invested in Profound Medical stock at $9.58, your return over the last 4 years would have been 6.64%, for an annualized return of 1.62% (not including any dividends or dividend reinvestments).

How much is Profound Medical's stock price per share?

(NASDAQ: PROF) Profound Medical stock price per share is $10.22 today (as of Jul 19, 2024).

What is Profound Medical's Market Cap?

(NASDAQ: PROF) Profound Medical's market cap is $249.66M, as of Jul 22, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Profound Medical's market cap is calculated by multiplying PROF's current stock price of $10.22 by PROF's total outstanding shares of 24,428,899.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.